Table 1.
Baseline characteristics of participants in the POSEIDON groups.
| POSEIDON | POSEIDON | POSEIDON | POSEIDON | |
|---|---|---|---|---|
| group 1 (n = 151) | group 2 (n = 101) | group 3 (n = 71) | group 4 (n = 105) | |
| Age (years) | 30.15 ± 2.50 | 38.80 ± 2.86 | 30.63 ± 2.77 | 38.77 ± 2.89 |
| BMI (kg/m2) | 23.44 ± 3.52 | 24.26 ± 2.94 | 23.54 ± 3.30 | 24.13 ± 2.74 |
| Infertility duration (years) | 3.39 ± 2.09 | 5.14 ± 4.46 | 3.54 ± 2.59 | 4.30 ± 3.52 |
| Cause of infertility | ||||
| Female factor | 109 (72.19) | 90 (89.11) | 55 (77.46) | 85 (80.95) |
| Male factor | 27 (17.88) | 7 (6.93) | 9 (12.68) | 12 (11.43) |
| Combined factors | 12 (7.95) | 3 (2.97) | 5 (7.04) | 8 (7.62) |
| Unexplained infertility | 3 (1.99) | 1 (0.99) | 2 (2.82) | 0 (0) |
| Baseline sex hormone | ||||
| FSH (IU/L) | 7.02 ± 1.71 | 7.14 ± 1.98 | 8.31 ± 3.44 | 8.98 ± 3.52 |
| LH (IU/L) | 5.32 ± 3.05 | 4.38 ± 2.05 | 4.18 ± 1.93 | 4.86 ± 3.40 |
| Estradiol (pg/mL) | 37.77 ± 14.73 | 41.53 ± 16.74 | 42.06 ± 17.52 | 43.56 ± 17.31 |
| AMH (ng/mL) | 3.22 ± 2.46 | 2.29 ± 1.70 | 0.77 ± 0.31 | 0.65 ± 0.33 |
| AFC | 11.87 ± 5.32 | 9.50 ± 4.35 | 6.86 ± 2.54 | 6.10 ± 2.38 |
| GH starting time | ||||
| Luteal phase of the previous cycle | 93 (61.59) | 57 (56.44) | 32 (45.07) | 57 (54.29) |
| Follicular phase of the previous cycle | 58 (38.41) | 44 (43.56) | 39 (54.93) | 48 (45.71) |
| GH dosage per day | ||||
| 2 IU | 129 (85.43) | 91 (90.10) | 62 (87.32) | 97 (92.38) |
| 1.5 IU | 8 (5.30) | 2 (1.98) | 3 (4.23) | 2 (1.90) |
| 1 IU | 14 (9.27) | 8 (7.92) | 6 (8.45) | 6 (5.71) |
All values presented as mean ± SD or n (%).
BMI, body mass index; FSH, follicle-stimulating hormone; LH, luteinizing hormone; AMH, anti-Müllerian hormone; AFC, antral follicle count; GH, growth hormone.